AstraZeneca Plc

Overview

AstraZeneca Plc (AstraZeneca) is a biopharmaceutical company, which discovers, produces and commercializes a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular, renal and metabolic diseases; and cancer, besides autoimmune, infection and neurological diseases. The company’s product portfolio includes biologics, prescription pharmaceuticals and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors and local representative offices. The company markets its products to primary care and specialty care physicians. The COVID-19 Vaccine AstraZeneca has been approved for conditional marketing or emergency use. The company operates in Europe, the Americas, Asia, Africa and Australasia. AstraZeneca is headquartered in Cambridge, Cambridgeshire, the UK.
Key Stats
Address
1 Francis Crick Avenue, CAMBRIDGE, CB2 0AA, United Kingdom
Headquarters

United Kingdom

Contact

44 20 73045000

No of Employees

76,100

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

AZN [LON]

Revenue (2020)

$26,617 m

9.2% (2020 vs 2019)
Net Income (2020)

$3,196 m

139.4% (2020 vs 2019)
Net Profit Margin

12 %

119.6% (2020 vs 2019)
Market Cap *

$178,355 m

EPS *

$2.4

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters AstraZeneca PlcJohnson & JohnsonF. Hoffmann-La Roche LtdNovartis AG
Key Information
Headquarters United Kingdom United States of America Switzerland Switzerland
Headquarter City CAMBRIDGE NEW BRUNSWICK BASEL BASEL
Headquarter State/Province - New Jersey - -
No. of Employees 76,100 134,500 101,465 109,000
Entity Type Public Public Public Public

Products & Services

AstraZeneca is a global, science-led biopharmaceutical business company. The company provides products in the following therapy areas.

Products
  • Cardiovascular and Metabolic Products
  • Gastrointestinal Products
  • Infection Products and Vaccines
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Services
  • Contract Manufacturing:
  • API Biologics (Protein and Peptide)
  • API Chemical
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
  • Etiam Rutrum Elit
Brands
  • Accolate
  • Arimidex
  • Atacand
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
  • Rutrum Elit
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Jeff Pott Chief Human Resources Officer; General Counsel Senior Management 2021 - Mr. Jeff Pott has been the General Counsel and the Chief Human Resources Officer of the company since 2021. Prior...
Leif Johansson Chairman Executive Board 2012 69 Mr. Leif Johansson has been the Chairman of the company since June 2012. Prior to this, he served at AB...
Pascal Soriot Chief Executive Officer; Director Executive Board 2012 61 Mr. Pascal Soriot has been the Chief Executive Officer and a Director of the company since 2012. Prior to this,...
Katarina Ageborg Executive Vice President - Sustainability Senior Management 2011 - Ms. Katarina Ageborg serves in the company as the Chief Compliance Officer and Executive Vice President of Sustainability since 2011....
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2021 Acquisitions/Mergers/Takeovers In July, the company completed the acquisition of Alexion Pharmaceuticals Inc, a pharmaceutical company.
2021 Divestiture In January, the company divested its heart failure and hypertension brand, Atacand to Cheplapharm Arzneimittel…
2021 Contracts/Agreements In January, the company along with Amgen, and Bristol Myers Squibb entered into a collaboration…
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam
2021 Quis autem vel Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam

Locations


Alexion Pharmaceuticals Inc

Address

121 Seaport Blvd, BOSTON
United States of America

Telephone

1 475 2302596

Website

alexion.com
Ardea Biosciences Inc

Address

9390 Towne Centre Drive, San Diego
United States of America

Telephone

1 858 6526500

Website

www.ardeabio.com
Astrazeneca Pharma India Ltd

Address

Ni 12Th Floor, Manyata Empassy Business, Park Rachenahalli,Outer Ring Rd Kr Puram, Rachenahalli, BANGALORE
India

Telephone

91 80 67748000

Website

www.astrazeneca.com/country-sites/india.html
AstraZeneca Luxembourg SA

Address

2A, rue Nicolas Bove, Luxembourg
Luxembourg

Telephone

352 37 8989

Website

www.astrazeneca.com/country-sites/luxembourg.html
AstraZeneca AB

Address

Karlebyhus, Astraallen, Sodertalje
Sweden

Telephone

46 855 326000

Website

www.astrazeneca.se
AstraZeneca Korea Ltd

Address

17th Floor, Luther Building 7-20, Sincheon-dong, Songpa-gu
South Korea

Telephone

82 2 21880800

Website

www.astrazeneca.co.kr
AstraZeneca Pharmaceuticals LP

Address

One MedImmune Way, Gaithersburg
United States of America

Telephone

1 302 8863000

Website

www.astrazeneca-us.com
AstraZeneca Canada Inc

Address

1004 Middlegate Road, Mississauga
Canada

Telephone

1 905 2777111

Website

www.astrazeneca.ca

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
01 Sep 2021 Thermo Fisher Scientific and AstraZeneca Enter into Agreement to Co-Develop NGS-based Companion Diagnostics Partnership AstraZeneca Plc; Thermo Fisher Scientific Inc
13 Aug 2021 A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder. Grant National Institute on Drug Abuse AstraZeneca Plc
05 Aug 2021 Sierra Oncology Enters into Licensing Agreement with AstraZeneca Licensing Agreement Sierra Oncology Inc AstraZeneca Plc
27 Jul 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
19 Jul 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
12 Jul 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

2.1K

Active Jobs

1.8K

Posted

2.6K

Closed

Job Trends

Latest Jobs

Job title Company Country
Technician, Filling-Operations AstraZeneca Plc United States
Production Technician I-Night Shift-Upstream-Friday-Monday Schedule AstraZeneca Plc United States
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar